Quality is no longer defined by compliance alone.
On May 12–13, 2026, the Pharma & Biotech Quality Summit will take place in Munich, bringing together senior quality and manufacturing leaders navigating this shift across pharma and biotech.
The agenda reflects what is changing in practice:
- AI moving from experimentation to validated use in GMP environments
- ATMPs and personalised medicine reshaping traditional QA frameworks
- Digital quality systems increasing both visibility and complexity
- Inspection readiness becoming a continuous, operational capability
With contributions from leaders across industry and regulatory bodies, the focus is on how to design, implement, manage and defend quality systems.
This is a space to align approaches with how the industry is evolving for people who's responsible for quality, release, and compliance.
